Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph A Coladonato

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of the American Society of Nephrology : JASN|October 28, 2005
Control of hyperphosphatemia among patients with ESRDJoseph A Coladonato
Advances in Renal Replacement Therapy|August 31, 2002
Secondary hyperparathyroidism and its therapy as a cardiovascular risk factor among end-stage renal disease patientsJoseph A Coladonato, Eberhard Ritz
Seminars in Dialysis|July 9, 2002
Study designs and their potential influence on conclusionsLynda Anne Szczech, Joseph A Coladonato, William F Owen
Seminars in Dialysis|March 5, 2002
An introduction to epidemiology and biostatistics and issues in interpretation of studiesLynda Anne Szczech, Joseph A Coladonato, William F Owen
Seminars in Dialysis|October 3, 2002
Key concepts in biostatistics: using statistics to answer the question "is there a difference?"Lynda Anne Szczech, Joseph A Coladonato, William F Owen
JAMA|March 12, 2002
Does time of day of hemodialysis affect survival?Todd F Griffith, Joseph A Coladonato, William F Owen
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 29, 2002
Does calcium kill ESRD patients--the skeptic's perspectiveJoseph A Coladonato, Lynda A Szczech, Eli A Friedman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2003
White blood cells as a novel mortality predictor in haemodialysis patientsDonal N Reddan, Preston S Klassen, Lynda A Szczech, et al.
Journal of the American Society of Nephrology : JASN|April 19, 2002
Trends in anemia management among US hemodialysis patientsJoseph A Coladonato, Diane L Frankenfield, Donal N Reddan, et al.
Seminars in Dialysis|October 3, 2002
How should hyperphosphatemia be managed in dialysis patients?Geoffrey Block, Jaime Uribarri, Joseph A Coladonato, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of the American Society of Nephrology : JASN|October 28, 2005
Control of hyperphosphatemia among patients with ESRDJoseph A Coladonato
Advances in Renal Replacement Therapy|August 31, 2002
Secondary hyperparathyroidism and its therapy as a cardiovascular risk factor among end-stage renal disease patientsJoseph A Coladonato, Eberhard Ritz
Seminars in Dialysis|July 9, 2002
Study designs and their potential influence on conclusionsLynda Anne Szczech, Joseph A Coladonato, William F Owen
Seminars in Dialysis|March 5, 2002
An introduction to epidemiology and biostatistics and issues in interpretation of studiesLynda Anne Szczech, Joseph A Coladonato, William F Owen
Seminars in Dialysis|October 3, 2002
Key concepts in biostatistics: using statistics to answer the question "is there a difference?"Lynda Anne Szczech, Joseph A Coladonato, William F Owen
JAMA|March 12, 2002
Does time of day of hemodialysis affect survival?Todd F Griffith, Joseph A Coladonato, William F Owen
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 29, 2002
Does calcium kill ESRD patients--the skeptic's perspectiveJoseph A Coladonato, Lynda A Szczech, Eli A Friedman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2003
White blood cells as a novel mortality predictor in haemodialysis patientsDonal N Reddan, Preston S Klassen, Lynda A Szczech, et al.
Journal of the American Society of Nephrology : JASN|April 19, 2002
Trends in anemia management among US hemodialysis patientsJoseph A Coladonato, Diane L Frankenfield, Donal N Reddan, et al.
Seminars in Dialysis|October 3, 2002
How should hyperphosphatemia be managed in dialysis patients?Geoffrey Block, Jaime Uribarri, Joseph A Coladonato, et al.
Pageof 2